Overview
Toru Nanmoku practices practicing medicine in Tsukuba, Japan.
Mr. Nanmoku is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Acute Monoblastic Leukemia (AmoL), Lymphofollicular Hyperplasia, Angioimmunoblastic T-cell Lymphoma, and Non-Hodgkin Lymphoma.
He is actively involved in clinical research, co-authoring 31 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Toru Nanmoku
Is Toru Nanmoku a top-rated expert for Acute Monoblastic Leukemia (AmoL)?
MediFind is an objective health platform that identifies experts based on real-world data. Toru Nanmoku is classified as an Advanced expert for Acute Monoblastic Leukemia (AmoL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Toru Nanmoku participate in research or clinical trials?
Yes. Toru Nanmoku has published 31 articles and abstracts on conditions like Acute Monoblastic Leukemia (AmoL). You can view a list of Toru Nanmoku's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Monoblastic Leukemia (AmoL)Mr. Nanmoku isAdvanced. Learn about Acute Monoblastic Leukemia (AmoL).
- Lymphofollicular HyperplasiaMr. Nanmoku isAdvanced. Learn about Lymphofollicular Hyperplasia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Mr. Nanmoku isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Megakaryoblastic LeukemiaMr. Nanmoku isExperienced. Learn about Acute Megakaryoblastic Leukemia.
- Acute Myeloid Leukemia (AML)Mr. Nanmoku isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Angioimmunoblastic T-cell LymphomaMr. Nanmoku isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- B-Cell LymphomaMr. Nanmoku isExperienced. Learn about B-Cell Lymphoma.
- Cardiac TamponadeMr. Nanmoku isExperienced. Learn about Cardiac Tamponade.
- CHARGE SyndromeMr. Nanmoku isExperienced. Learn about CHARGE Syndrome.
- Chronic T-Cell Leukemia (CTCL)Mr. Nanmoku isExperienced. Learn about Chronic T-Cell Leukemia (CTCL).
- Follicular LymphomaMr. Nanmoku isExperienced. Learn about Follicular Lymphoma.
- Immune Defect due to Absence of ThymusMr. Nanmoku isExperienced. Learn about Immune Defect due to Absence of Thymus.
- LeukemiaMr. Nanmoku isExperienced. Learn about Leukemia.
- Marginal Zone Lymphoma (MZL)Mr. Nanmoku isExperienced. Learn about Marginal Zone Lymphoma (MZL).
- MononucleosisMr. Nanmoku isExperienced. Learn about Mononucleosis.
- Non-Hodgkin LymphomaMr. Nanmoku isExperienced. Learn about Non-Hodgkin Lymphoma.
- Prolymphocytic LeukemiaMr. Nanmoku isExperienced. Learn about Prolymphocytic Leukemia.
- T-Cell LymphomaMr. Nanmoku isExperienced. Learn about T-Cell Lymphoma.
- Waldenstrom MacroglobulinemiaMr. Nanmoku isExperienced. Learn about Waldenstrom Macroglobulinemia.